IL113450A - Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby - Google Patents

Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby

Info

Publication number
IL113450A
IL113450A IL11345095A IL11345095A IL113450A IL 113450 A IL113450 A IL 113450A IL 11345095 A IL11345095 A IL 11345095A IL 11345095 A IL11345095 A IL 11345095A IL 113450 A IL113450 A IL 113450A
Authority
IL
Israel
Prior art keywords
cyclodextrin
complexes
base
preparation
high solubility
Prior art date
Application number
IL11345095A
Other languages
English (en)
Other versions
IL113450A0 (en
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of IL113450A0 publication Critical patent/IL113450A0/xx
Publication of IL113450A publication Critical patent/IL113450A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL11345095A 1994-04-22 1995-04-20 Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby IL113450A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940790A IT1269578B (it) 1994-04-22 1994-04-22 Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.

Publications (2)

Publication Number Publication Date
IL113450A0 IL113450A0 (en) 1995-07-31
IL113450A true IL113450A (en) 1999-05-09

Family

ID=11368715

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11345095A IL113450A (en) 1994-04-22 1995-04-20 Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby

Country Status (13)

Country Link
US (1) US5773029A (fr)
EP (1) EP0756493B1 (fr)
AT (1) ATE194777T1 (fr)
AU (1) AU2307695A (fr)
CA (1) CA2188388A1 (fr)
DE (1) DE69518070T2 (fr)
ES (1) ES2148512T3 (fr)
HK (1) HK1013627A1 (fr)
IL (1) IL113450A (fr)
IT (1) IT1269578B (fr)
PT (1) PT756493E (fr)
WO (1) WO1995028965A1 (fr)
ZA (1) ZA953206B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997018245A1 (fr) * 1995-11-14 1997-05-22 Farmarc Nederland B.V. Complexe de naproxene et de beta-cyclodextrine
UA57734C2 (uk) 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
EP0811386B1 (fr) * 1996-05-07 2004-09-29 Pfizer Inc. Méthode de sélection d'un sel pour fabrication d'un complexe d'inclusion
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6939863B2 (en) 2002-01-04 2005-09-06 Wei-Jan Chen Prevention of atherosclerosis and restenosis
CA2480826C (fr) * 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
ES2286177T3 (es) * 2002-06-17 2007-12-01 Chiesi Farmaceutici S.P.A. Procedimiento para la preparacion de piroxicam: compuestos de inclusion de betaciclodextrina.
BR0313602A (pt) * 2002-08-20 2005-06-21 Bristol Myers Squibb Co Método e formulação de complexo de aripiprazol
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
DE10260873A1 (de) 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
DE10260872B4 (de) * 2002-12-23 2013-09-26 Beiersdorf Ag Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
US20070020578A1 (en) * 2005-07-19 2007-01-25 Scott Robert R Dental curing light having a short wavelength LED and a fluorescing lens for converting wavelength light to curing wavelengths and related method
WO2006034147A2 (fr) * 2004-09-16 2006-03-30 Abraxis Bioscience, Inc. Compositions et procedes de preparation et d'administration de medicaments faiblement solubes dans l'eau
US8772346B2 (en) * 2005-11-09 2014-07-08 Torrent Pharmaceuticals Limited Pharmaceutical composition
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
US20100311838A1 (en) 2009-05-29 2010-12-09 Pipkin James D Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
CN108210501B (zh) * 2016-12-14 2019-03-08 中国人民解放军军事医学科学院毒物药物研究所 一种磺酰脲类药物的注射用药物组合物及其制备方法
TW202302117A (zh) * 2021-03-04 2023-01-16 美商渤健切薩皮克有限公司 低吸附格列本脲調配物及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
BE1001704A3 (fr) * 1987-12-22 1990-02-13 Glaxo Group Ltd Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique.
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina

Also Published As

Publication number Publication date
DE69518070T2 (de) 2001-01-11
IT1269578B (it) 1997-04-08
ATE194777T1 (de) 2000-08-15
US5773029A (en) 1998-06-30
HK1013627A1 (en) 1999-09-03
EP0756493B1 (fr) 2000-07-19
IL113450A0 (en) 1995-07-31
ITMI940790A1 (it) 1995-10-22
PT756493E (pt) 2000-10-31
EP0756493A1 (fr) 1997-02-05
ITMI940790A0 (it) 1994-04-22
ES2148512T3 (es) 2000-10-16
CA2188388A1 (fr) 1995-11-02
WO1995028965A1 (fr) 1995-11-02
AU2307695A (en) 1995-11-16
DE69518070D1 (de) 2000-08-24
ZA953206B (en) 1996-01-03

Similar Documents

Publication Publication Date Title
IL113450A (en) Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby
IL136503A0 (en) Adamantane derivatives
PL340906A1 (en) Adamantane derivatives
NO11062A (no) Farmasöytisk sammensetning og matvaresupplement
MY113274A (en) Omeprazole magnesium salt form
SE9704546D0 (sv) Novel compounds
DE59410052D1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
DE69532580D1 (de) Neue antagonistische verbindungen
PL326322A1 (en) Ciral methylphenyloxyazolydinones
GEP20002206B (en) Cryptophycins, Method for its Production, Pharmaceutical Composition on Their basis and Use
AU7956291A (en) New salt form
FI932388A (fi) 8-en-19,11b-bryggsteroider, deras framstaellning och farmaceutiska preparat innehaollande dem
GR3034155T3 (en) Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
HU9603128D0 (en) Derivatives of aminosulfonic acids, utilization of the same in the synthesis of pseudopeptides and process for their preparation
IL115740A0 (en) A childproof package for active substance patches and a process for the production thereof
CZ20022240A3 (cs) Mannichovy báze substituovaného 1-a 2-naftolu
HUT76806A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them
JO1822B1 (en) A new form of a compound

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees